Clinical characteristics and prognostic factors of non-tuberculous mycobacterial disease in patients with rheumatoid arthritis

被引:0
|
作者
Kim, Hyemin [1 ]
Lee, Soyoung [1 ]
Kim, Ji-Won [1 ]
Jung, Ju -Yang [1 ]
Suh, Chang -Hee [1 ]
Kim, Hyoun-Ah [1 ,2 ]
机构
[1] Ajou Univ, Dept Rheumatol, Sch Med, Suwon, South Korea
[2] Ajou Univ, Sch Med, Dept Rheumatol, 164 Worldcup Ro, Suwon 16499, South Korea
关键词
Rheumatoid arthritis; Nontuberculous mycobacteria; Prognosis; Risk factor; LUNG-DISEASE; INFECTION; CLASSIFICATION; PREDICTORS; DIAGNOSIS; CRITERIA; RISK;
D O I
10.3904/kjim.2023.193
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: This study aimed to identify the clinical characteristics of patients with concurrent rheumatoid arthritis (RA) and suspected non-tuberculous mycobacterial (NTM) infections as well as determine their prognostic factors. Methods: We retrospectively reviewed the medical records of 91 patients with RA whose computed tomography (CT) find-ings suggested NTM infection. Subsequently, we compared the clinical characteristics between patients with and without clinical or radiological exacerbation of NTM-pulmonary disease (PD) and investigated the risk factors for the exacerbation and associated mortality. Results: The mean age of patients with RA and suspected NTM-PD was 65.0 +/- 10.2 years. The nodular/bronchiectatic (NB) form of NTM-PD was the predominant radiographic feature (78.0%). During follow-up, 36 patients (41.9%) experienced a radiological or clinical exacerbation of NTM-PD, whereas 12 patients (13.2%) died. Combined interstitial lung disease (ILD), microbiologically confirmed NTM-PD, and NB with the fibrocavitary (FC) form on chest CT were identified as risk factors for the clinical or radiological exacerbation of NTM-PD. Hydroxychloroquine use was identified as a good prognostic factor. Conversely, history of tuberculosis, ILD, smoking, microbiologically confirmed NTM-PD, and NB with the FC form on chest CT were identified as poor prognostic factors for mortality in suspected NTM-PD. Conclusions: ILD and NB with the FC form on chest CT were associated with NTM-PD exacerbation and mortality. Hydroxychloroquine use may lower the risk of NTM-PD exacerbation. Therefore, radiographic features and presence of ILD should be considered when predicting the prognosis of patients with RA and suspected NTM-PD.
引用
收藏
页码:172 / 183
页数:16
相关论文
共 50 条
  • [1] Clinical course of nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis
    Kwak, Nakwon
    Moon, Jinyoung
    Kim, Joong-Yub
    Park, Jun Won
    Yim, Jae-Joon
    ADVANCES IN RHEUMATOLOGY, 2024, 64 (01)
  • [2] Non-tuberculous mycobacterial pulmonary disease: a clinical update
    Rokadiya, S.
    Millar, F. R.
    Tiberi, S.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2018, 79 (08) : C118 - C122
  • [3] Factors predisposing to non-tuberculous mycobacterial lung disease in the patients with respiratory isolates of non-tuberculous mycobacteria
    Szturmowicz, Monika
    Siemion-Szczesniak, Izabela
    Wyrostkiewicz, Dorota
    Klatt, Magdalena
    Brzezinska, Sylwia
    Zaboset, Anna
    Lewandowska, Anna
    Filipczak, Dorota
    Oniszh, Karina
    Skoczylas, Agnieszka
    Augustynowicz-Kopec, Ewa
    Kus, Jan
    ADVANCES IN RESPIRATORY MEDICINE, 2018, 86 (06) : 261 - 267
  • [4] Physiotherapy for patients with non-tuberculous mycobacterial disease
    Polastri, Massimiliano
    Comellini, Vittoria
    INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 2021, 28 (02)
  • [5] Evaluation of treatment response with serial CT in patients with non-tuberculous mycobacterial pulmonary disease
    Dettmer, Sabine
    Heiss-Neumann, Marion
    Wege, Sabine
    Maske, Hannah
    Ringshausen, Felix C.
    Joean, Oana
    Theissig, Nicole
    Ewen, Raphael
    Wacker, Frank
    Rademacher, Jessica
    EUROPEAN RADIOLOGY, 2025, 35 (02) : 798 - 805
  • [6] Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, Mali
    Kone, B.
    Sarro, Y. S.
    Maiga, M.
    Sanogo, M.
    Somboro, A. M.
    Diarra, B.
    Togo, A. C. G.
    Coulibaly, N.
    Dembele, B. P. P.
    Goita, D.
    Baya, B.
    Kone, A.
    Diabate, S.
    Polis, M. A.
    Belson, M.
    Dao, S.
    Orsega, S.
    Achenbach, C. J.
    Murphy, R. L.
    Diallo, S.
    Siddiqui, S.
    EPIDEMIOLOGY AND INFECTION, 2018, 146 (03) : 354 - 358
  • [7] CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry
    Funada, Masashi
    Miyazaki, Yusuke
    Nakayamada, Shingo
    Sonomoto, Koshiro
    Kubo, Satoshi
    Miyagawa, Ippei
    Tanaka, Hiroaki
    Tanaka, Yoshiya
    RMD OPEN, 2024, 10 (02):
  • [8] Non-tuberculous mycobacterial pulmonary disease
    Cowman, Steven
    van Ingen, Jakko
    Griffith, David E.
    Loebinger, Michael R.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (01)
  • [9] Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
    Kumar, Kartik
    Kon, Onn Min
    MICROORGANISMS, 2021, 9 (11)
  • [10] Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease
    Ratnatunga, Champa N.
    Tungatt, Katie
    Proietti, Carla
    Halstrom, Sam
    Holt, Michael R.
    Lutzky, Viviana P.
    Price, Patricia
    Doolan, Denise L.
    Bell, Scott C.
    Field, Matt A.
    Kupz, Andreas
    Thomson, Rachel M.
    Miles, John J.
    FRONTIERS IN IMMUNOLOGY, 2022, 13